Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32105622

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Apr
First author
Hong DS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):472-474. doi: 10.1016/S1470-2045(20)30026-7.
    note
    Source null
    related pmid
    32105623
    relationship
    Comment in

Authors and identifiers

  1. name
    Hong DS
    type
    Author
  2. name
    DuBois SG
    type
    Author
  3. name
    Kummar S
    type
    Author
  4. name
    Farago AF
    type
    Author
  5. name
    Albert CM
    type
    Author
  6. name
    Rohrberg KS
    type
    Author
  7. name
    van Tilburg CM
    type
    Author
  8. name
    Nagasubramanian R
    type
    Author
  9. name
    Berlin JD
    type
    Author
  10. name
    Federman N
    type
    Author
  11. name
    Mascarenhas L
    type
    Author
  12. name
    Geoerger B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hong DS
    type
    Author
  2. name
    DuBois SG
    type
    Author
  3. name
    Kummar S
    type
    Author
  4. name
    Farago AF
    type
    Author
  5. name
    Albert CM
    type
    Author
  6. name
    Rohrberg KS
    type
    Author
  7. name
    van Tilburg CM
    type
    Author
  8. name
    Nagasubramanian R
    type
    Author
  9. name
    Berlin JD
    type
    Author
  10. name
    Federman N
    type
    Author
  11. name
    Mascarenhas L
    type
    Author
  12. name
    Geoerger B
    type
    Author
bibliography ids
  1. nci-bib-86537c899038073c1b37c94e
book metadata
content sha256
b0c6975e90ae988958c221a59c553c12e88b848894a8f070d7d8ec4160124690
document type
citation
dois
  1. 10.1016/S1470-2045(19)30856-3
electronic publication date
display
2020 Feb 24
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32105622
immutable id
pubmed:32105622@b0c6975e90ae988958c221a59c553c12e88b848894a8f070d7d8ec4160124690
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
531-540
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):472-474. doi: 10.1016/S1470-2045(20)30026-7.
    note
    Source null
    related pmid
    32105623
    relationship
    Comment in
outcomes validated
false
pmid
32105622
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
e5554fe9a1c5b41b405456c2f272b0133ec78f306a24a3775350b8101f5cbadc
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Apr
precision
month
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32105622/
title
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.

Preserved source evidence · Not medical advice